|
Session 113-Poster Abstracts
Prevalence and Consequences of Transmitted Drug Resistance
Wednesday, 2-4 pm; Poster Hall |
| 580 |
Prevalence of Transmitted Antiretroviral Drug Resistance among Newly-diagnosed HIV-1-infected Persons, US, 2007
David Kim*, W Wheeler, R Ziebell, J Johnson, J Prejean, W Heneine, I Hall, and US Variant, Atypical, and Resistant HIV Surveillance Coordinators
CDC, Atlanta, GA, US |
581
 |
Prevalence of Mutations Associated with Transmitted Drug Resistant HIV among BED Recent Versus Long-term Infections, US, 2006
Joseph Prejean*1, R Ziebell2, W Wheeler1, D Pieniazek1, J Johnson1, I Hall1, and Variant, Atypical and Resistant HIV Surveillance Group
1CDC, Atlanta, GA, US and 2The Ginn Group Inc, Peachtree City, GA, US |
582
|
Prevalence and Virologic Consequences of Transmitted Drug Resistance Mutations in Uganda
Guinevere Lee*1, I Kizogi2, D Bangsberg3, N Emenyonu2, J Bennett4, P Hunt4, D Knapp1, C Brumme1, R Harrigan1, J Martin4, and the UARTO Study Group
1BC Ctr for Excellence in HIV/AIDS, Vancouver, Canada; 2Mbarara Univ of Sci and Tech, Uganda; 3Harvard Med Sch, Boston, MA, US; and 4Univ of California, San Francisco, US |
583
|
Association with Transmission of M184V/I and a Reduced Viral Load in Therapy-naïve Patients in the CFAR Network of Integrated Clinical Systems Cohort
Art Poon*1, J Aldous2, C Mathews2, M Kitahata3, J Kahn4, M Saag5, B Rodriguez6, S Boswell7, S Frost8, R Haubrich2, and the CNICS 002 Study Team
1BC Ctr for Excellence in HIV/AIDS, Vancouver, Canada; 2Univ of California, San Diego, US; 3Univ of Washington, Seattle, US; 4Univ of California, San Francisco, US; 5Univ of Alabama at Birmingham, US; 6Case Western Reserve Univ, Cleveland, OH, US; 7Fenway Community Hlth, Harvard Med Sch, Boston, MA, US; and 8Univ of Cambridge, UK |
|
